Program Description: 
This is a working tumor board that covers active cases of patients with bone and soft tissue lesions associated with sarcoma (connective tissue neoplasms), metastatic carcinoma, and some metabolic bone disease. We discuss treatment plans/options/protocols for newly diagnosed and/or established adult musculoskeletal oncology patients based on the most up to date data/literature, evidence- based medicine, outcomes of our own research, and data accumulated at our tumor board via our ongoing data base. This series continues to grow as new treatment modalities that are founded/developed based on the on-going experience of the providers who are dedicated to attending our tumor board. These relationships continue to provide new collaborations, increase respect/trust, referrals, utilization of treatment resources and consistent continuity of care.
Key Words: sarcoma, connective tissue neoplasms, metastatic carcinoma, metabolic bone diseases
Target audience: 
  • Physician
  • Nurse Practitioner
  • Physician Assistant
  • Nurse
Learning objectives: 

Participants who engage in this educational intervention will be able to:

  • Discuss treatment outcomes in comparison to the standard of care in evidence-based medicine and literature.
  • Collaborate research efforts and establish research studies based on our findings and publish our outcomes.
  • Continue to strengthen the multidisciplinary relationships that have evolved over the many years since this tumor board was established.
  • Apply recent updates to treatment plans and protocols based on the discussions of the patient’s treatment at tumor board
  • Expand our discussions to include the most recent and relevant literature evaluations on musculoskeletal oncology and disease protocols and treatment outcomes
  • Continue to collaborate as a multidisciplinary unit to treat the patient as a whole and utilize treatment resources efficiently
  • Publish research that is up to date and relevant to current literature
Faculty & credentials: 

Activity Directors:

Donald Hackbarth, MD


Department of Orthopedic Surgery

Medical College of Wisconsin-Froedtert 


In accordance with the ACCME® Standards for Integrity and Independence in Accredited Continuing Education, Standard 3, all in control of content must disclose any relevant financial relationships. The following in control of content had no relevant financial relationships to disclose.

  • Donald Hackbarth, MD

The following persons in control of content disclosed the following financial relationships which were reviewed via the MCW conflict of interest mitigation process and addressed.

Hackbarth, Donald, MD, FACS, FAAOSMTF BiologicsBoard Member



Lori Hollingsworth-Burds
Series date: 
01/01/2023 - 7:45am CST to 12/31/2023 - 8:45am CST

ACCME Accreditation Statement:
The Medical College of Wisconsin is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

AMA Credit Designation Statement:
The Medical College of Wisconsin designates this live activity for a maximum of 1.00 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Hours of Participation for Allied Health Care Professionals:
The Medical College of Wisconsin designates this activity for up to 1.00 hours of participation for continuing education for allied health professionals.

Group description: 
Musculoskeletal Oncology Tumor Board 2023
Series location: 
Froedtert Hospital
9200 W Wisconsin Avenue
Cancer Center Room (L)
Wauwatosa, WI 53226
United States


Session Date
Musculoskeletal Oncology Tumor Board 01/04/2023 - 7:45am to 8:45am CST
Musculoskeletal Oncology Tumor Board 01/11/2023 - 7:45am to 8:45am CST
Musculoskeletal Oncology Tumor Board 01/18/2023 - 7:45am to 8:45am CST
Musculoskeletal Oncology Tumor Board 01/25/2023 - 7:45am to 8:45am CST
Musculoskeletal Oncology Tumor Board 02/01/2023 - 7:45am to 8:45am CST
Musculoskeletal Oncology Tumor Board 02/08/2023 - 7:45am to 8:45am CST
Musculoskeletal Oncology Tumor Board 02/15/2023 - 7:45am to 8:45am CST
Musculoskeletal Oncology Tumor Board 02/22/2023 - 7:45am to 8:45am CST